Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06053645 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Weight of Cardiovascular Disease

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 9 months later Jul 2026 → May 2027
See other at-risk trials from Mayo Clinic

Record History

  1. Primary and study completion pushed from Jul 2026 to May 2027 Enrollment closed, study ongoing · Final enrollment: 31 participants (planned 60) · Eligibility criteria expanded, about 14 words · 2 more Show all 6 changesShow less
    • Enrollment closed, study ongoing
    • Final enrollment: 31 participants (planned 60)
    • Eligibility criteria expanded, about 14 words
    • Secondary endpoints: details revised at 12 of 17 entries
    • Site details revised
  2. Primary and study completion dates: Sep 2025 to Jul 2026v9
  3. Site contact updatedv8
  4. Start date changed from estimate of May 2024 to Apr 22, 2024v7
  5. Start date: Mar 2024 to May 2024v6
Show 4 earlier versionsHide 4 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting Site details revisedv5 Show all 2 changesShow less
    • Site details revised
  2. Start date: Jan 2024 to Mar 2024 Eligibility criteria shortened, about 8 words · Secondary endpoints: 18 to 17v4 Show all 3 changesShow less
    • Eligibility criteria shortened, about 8 words
    • Secondary endpoints: 18 to 17

    See this version in full on ClinicalTrials.gov ↗

  3. Start date: Nov 2023 to Jan 2024 Secondary endpoints: 17 to 18v3 Show all 2 changesShow less
    • Secondary endpoints: 17 to 18

    See this version in full on ClinicalTrials.gov ↗

  4. Start date: Sep 2023 to Nov 2023v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Mayo Clinic
1,019 trials monitored
See 123 trials at risk
Obesity
3,560 trials monitored
See 142 trials at risk
Heart Disease
2,136 trials monitored
See 109 trials at risk
The purpose of this study is to evaluate the impact of a cardiometabolic clinic on percent body weight loss, body mass index (BMI), and visceral adiposity distribution in obese adults with cardiovascular disease (CVD) at 12 months.
Trial Details
NCT Number NCT06053645
Lead Sponsor Mayo Clinic
Conditions Cardiovascular Diseases, Obesity
Enrollment 31 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov